Li et al., 2004 - Google Patents
Sustained delivery and expression of plasmid DNA based on biodegradable polyester, poly (D, L-lactide-co-4-hydroxy-L-proline)Li et al., 2004
- Document ID
- 4597891159749879231
- Author
- Li Z
- Huang L
- Publication year
- Publication venue
- Journal of controlled release
External Links
Snippet
Gene expression mediated by a non-viral vector usually lasts only a few days. The objective of this study was to synthesize and characterize a non-toxic, polymeric gene carrier, poly (d, l- lactide-co-4-hydroxy-l-proline)(PLHP) for sustained gene delivery. The copolymer was …
- 229920003013 deoxyribonucleic acid 0 title abstract description 19
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
- A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nuclic acid
- A61K48/0041—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nuclic acid the non-active part being polymeric
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/30—Macromolecular compounds
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, copolymers of polyalkylene glycol or poloxamer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Li et al. | Sustained delivery and expression of plasmid DNA based on biodegradable polyester, poly (D, L-lactide-co-4-hydroxy-L-proline) | |
| Liu et al. | A mPEG-PLGA-b-PLL copolymer carrier for adriamycin and siRNA delivery | |
| Liu et al. | pH-sensitive nano-systems for drug delivery in cancer therapy | |
| Storrie et al. | Sustained delivery of plasmid DNA from polymeric scaffolds for tissue engineering | |
| Han et al. | Effects of hydrophobic core components in amphiphilic PDMAEMA nanoparticles on siRNA delivery | |
| Csaba et al. | PLGA: poloxamer and PLGA: poloxamine blend nanostructures as carriers for nasal gene delivery | |
| Yin et al. | Synthesis and biomedical applications of functional poly (α-hydroxy acids) via ring-opening polymerization of O-carboxyanhydrides | |
| Jeong et al. | Novel polymer− DNA hybrid polymeric micelles composed of hydrophobic poly (D, L-lactic-co-glycolic acid) and hydrophilic Oligonucleotides | |
| Waite et al. | PAMAM-RGD conjugates enhance siRNA delivery through a multicellular spheroid model of malignant glioma | |
| Ding et al. | Self-assembly of biodegradable polyurethanes for controlled delivery applications | |
| Bikram et al. | Biodegradable Poly (ethylene glycol)-c o-poly (l-lysine)-g-histidine Multiblock Copolymers for Nonviral Gene Delivery | |
| Samal et al. | Cationic polymers and their therapeutic potential | |
| Wong et al. | PEI-g-chitosan, a novel gene delivery system with transfection efficiency comparable to polyethylenimine in vitro and after liver administration in vivo | |
| Liu et al. | Biodegradation, biocompatibility, and drug delivery in poly (ω-pentadecalactone-co-p-dioxanone) copolyesters | |
| Ding et al. | The optimization of polymalic acid peptide copolymers for endosomolytic drug delivery | |
| Gu et al. | Self-assembled carboxymethyl poly (l-histidine) coated poly (β-amino ester)/DNA complexes for gene transfection | |
| Pellis et al. | Enzyme-catalyzed functionalization of poly (L-lactic acid) for drug delivery applications | |
| Wang et al. | Synthesis of amphiphilic alternating polyesters with oligo (ethylene glycol) side chains and potential use for sustained release drug delivery | |
| Wang et al. | Synthesis and characterization of cationic polymeric nanoparticles as simvastatin carriers for enhancing the osteogenesis of bone marrow mesenchymal stem cells | |
| Wang et al. | Efficient RNA delivery by integrin-targeted glutathione responsive polyethyleneimine capped gold nanorods | |
| Hosseinkhani et al. | Biodegradable nanoparticles for gene therapy technology | |
| Chen et al. | Enzymatic PEGylated poly (lactone-co-β-amino ester) nanoparticles as biodegradable, biocompatible and stable vectors for gene delivery | |
| JP2003505473A (en) | Biodegradable polycation compositions for delivery of anionic polymers | |
| Hehir et al. | Recent advances in drug delivery systems based on polypeptides prepared from N‐carboxyanhydrides | |
| US10995156B2 (en) | Acid-degradable and bioerodible modified polyhydroxylated materials |